No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹1,824.9Prev. Close
₹1,836Turnover(Lac.)
₹844.14Day's High
₹1,880.9Day's Low
₹1,809.352 Week's High
₹2,100.752 Week's Low
₹1,336.6Book Value
₹121.97Face Value
₹10Mkt Cap (₹ Cr.)
11,428.37P/E
56.16EPS
32.63Divi. Yield
0.55No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 |
|---|---|---|---|---|
Equity Capital | 61.16 | 61.16 | 61.16 | 61.16 |
Preference Capital | 0 | 0 | 0 | 0.39 |
Reserves | 684.81 | 544.56 | 419.02 | 346.75 |
Net Worth | 745.97 | 605.72 | 480.18 | 408.3 |
Minority Interest |
No Record Found
No Record Found
No Record Found
| Particulars (Rupees in Crores.) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 |
|---|---|---|---|---|
Gross Sales | 1,403.18 | 1,196.42 | 1,014.47 | 884.05 |
Excise Duty | 0 | 0 | 0 | 0 |
Net Sales | 1,403.18 | 1,196.42 | 1,014.47 | 884.05 |
Other Operating Income | 0 | 0 | 0 | 0 |
Other Income | 10.92 | 6.31 | 6.46 | 7.28 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,838.3 | 146.85 | 4,40,793.82 | 608.7 | 0.87 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 6,743 | 67.22 | 1,78,956.35 | 756 | 0.44 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,429.8 | 67.72 | 1,49,819.64 | 467 | 0.86 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,351.8 | 31.77 | 1,09,370.14 | 384.64 | 0.96 | 3,840.92 | 423.36 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,070.8 | 29.18 | 1,07,757.6 | 1,722 | 0.09 | 3,564.6 | 235.25 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman(Non Exe)&Dir(Non-Ind)
KIRTIKUMAR LAXMIDAS MEHTA
ED / MD / CEO / Promoter
NIRAVKUMAR KIRTIKUMAR MEHTA
ED / Joint MD / Promoter
ANKUR KIRTIKUMAR MEHTA
E D & Wholetime Director
VIRAL BHUPENDRABHAI SITWALA
Independent Non Exe. Director
Ameet Desai
Independent Non Exe. Director
Monica Kanuga
Independent Non Exe. Director
Shirish Gundopant Belapure
Independent Non Exe. Director
Bhaskar Vemban Iyer
Company Sec. & Compli. Officer
Chetna Darajiya
Corona House C-Mondeal Busines,
#NAME?,
Gujarat - 380059
Tel: +91 79 4023 3000
Website: http://www.coronaremedies.com
Email: complianceofficer@coronaremedies.com
Office No S6-2,
Pinnacle Busine.Park, Mahakali Caves Road,
Mumbai - 400093
Tel: 91-22-62638200
Website: www.bigshareonline.com
Email: investor@bigshareonline.com / info@bigshareonline.com
Summary
Corona Remedies Limited was originally incorporated as CORONA Remedies Private Limited, a private limited company, dated August 27, 2004, issued by the Assistant Registrar of Companies, Gujarat at Dad...
Read More
Reports by Corona Remedies Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.